KENNETH BATE Insider Trading $AVEO AVEO PHARMACEUTICALS, INC.
Get free email notifications about insider trading for KENNETH BATE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).
KENNETH BATE in AVEO PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 30 2020
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KENNETH BATE in AVEO PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
| Jun 13 2019 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 0.76 | 40,000 | 30,400 | 40,000 | |
| Jun 19 2018 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 2.27 | 40,000 | 90,800 | 40,000 | |
| Jun 23 2017 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 0.70 | 57,857 | 40,500 | 57,857 | |
| Jun 23 2017 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 0.70 | 20,000 | 14,000 | 20,000 | |
| May 31 2016 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 0.92 | 44,021 | 40,499 | 44,021 | |
| May 31 2016 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 0.92 | 20,000 | 18,400 | 20,000 | |
| Jun 01 2015 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 2.00 | 20,000 | 40,000 | 20,000 | |
| Apr 06 2015 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 1.61 | 25,155 | 40,500 | 25,155 |
Page: 1